China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 138,710 | 129,609 | 131,723 | 104,487 | 84,975 |
Marketable Securities | N/A | N/A | 2,728 | 1,347 | N/A |
Receivables | 14,570 | 11,206 | 16,536 | 23,383 | 27,329 |
Inventories | 76,757 | 75,679 | 68,243 | 69,744 | 70,584 |
Other current assets | 0 | 0 | 1,905 | 1,768 | 1,799 |
TOTAL | $235,985 | $222,160 | $223,693 | $202,794 | $186,920 |
Non-Current Assets | |||||
PPE Net | 55,165 | 51,325 | 39,154 | 40,439 | 40,971 |
Investments And Advances | 10,726 | 10,537 | 10,067 | 9,888 | 9,430 |
Intangibles | 9,177 | 9,360 | 10,118 | 10,890 | 11,647 |
Other Non-Current Assets | 18,563 | 17,665 | 22,594 | 7,856 | 5,194 |
TOTAL | $93,632 | $88,888 | $81,932 | $69,073 | $67,242 |
Total Assets | $329,616 | $311,047 | $305,625 | $271,866 | $254,162 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 4,788 | 7,935 | 11,081 | N/A | 4,752 |
Accounts payable and accrued liabilities | 30,717 | 32,414 | 33,554 | 31,448 | 32,559 |
Other current liabilities | 4,327 | 2,857 | 3,941 | 5,287 | 9,751 |
TOTAL | $45,641 | $47,719 | $56,820 | $42,244 | $53,338 |
Non-Current Liabilities | |||||
aiOther Non-Current Liabilities | -3,768 | -1,382 | -4,512 | -6,409 | -4,416 |
TOTAL | $6,158 | $5,909 | $1,418 | $1,824 | $1,926 |
Total Liabilities | $51,799 | $53,628 | $58,238 | $44,067 | $55,264 |
Shareholders' Equity | |||||
Shares Outstanding, K | 26,845 | 26,822 | 26,569 | 26,539 | 25,601 |
Common Shares | 3 | 3 | 3 | 3 | 3 |
Retained earnings | 134,059 | 119,143 | 113,334 | 99,717 | 86,878 |
Other shareholders' equity | 78,718 | 76,022 | 73,877 | 69,107 | 62,217 |
TOTAL | $277,818 | $257,419 | $247,387 | $227,799 | $198,899 |
Total Liabilities And Equity | $329,616 | $311,047 | $305,625 | $271,866 | $254,162 |